ESSValidated Hypersomnolence Screening Tool
Situational Assessment
1. Sitting and reading
2. Watching TV
3. Sitting inactive in a public place
4. As a passenger in a car for an hour
5. Lying down to rest in the afternoon
6. Sitting and talking to someone
7. Sitting quietly after lunch (no alcohol)
8. In a car, while stopped for a few minutes
Awaiting Input
Please complete all 8 scenarios to generate the total sleepiness index and clinical guidance.
Guidelines & Evidence
Verified
Last Review: 2026
When to Use
What the ESS Measures
The ESS measures a person's "average sleep propensity" (ASP) — their usual tendency to doze off or fall asleep in daily life, not their feelings of fatigue or transient drowsiness. Unlike the Karolinska Sleepiness Scale (which measures momentary alertness), the ESS captures a stable trait over weeks to months. It specifically distinguishes dozing behavior (falling asleep) from "weariness from exertion" (fatigue), which are often confused. The eight items were chosen a priori to represent activities with widely varying "somnificity" (sleep-inducing potential), from low (sitting and talking to someone) to high (lying down to rest in the afternoon).
Primary Indications
Obstructive Sleep Apnea (OSA) – Screening for excessive daytime sleepiness; monitoring response to CPAP therapy; MCID for improvement is 2-3 points
Narcolepsy – Quantifying severe hypersomnolence (ESS usually 16-24); distinguishing from normal sleepiness (specificity >95% at score >15)
Idiopathic Hypersomnia – Initial assessment and treatment monitoring (stimulants, sodium oxybate)
Shift Work Disorder – Documenting excessive sleepiness in night shift workers
Multiple Sclerosis-related fatigue – Differentiating sleepiness from fatigue (ESS specifically measures dozing, not weariness)
Parkinson's Disease – Screening for excessive daytime sleepiness (common non-motor symptom)
Pre-driving risk assessment – Very high scores (>15) may indicate increased drowsy driving risk, but ESS should NOT be used alone for license decisions
Clinical trial endpoint – Common primary or secondary outcome in sleep disorder interventions
Pre-procedural screening (e.g., bariatric surgery, sedation) – Identifying undiagnosed OSA risk (high ESS prompts sleep study)
Interpretation of Score Ranges (Per Official ESS Guidelines)
| Score Range | Classification | Clinical Significance | Typical Populations |
|---|---|---|---|
| 0-5 | Lower Normal Daytime Sleepiness | Rarely or never dozes in routine situations; may be unusually alert or underestimating sleepiness | Healthy adults without sleep disorders; elite athletes; some shift workers after adaptation |
| 6-10 | Higher Normal Daytime Sleepiness | Normal range (mean 4.6, SD 2.8 in healthy Australians without chronic sleep disorders). Zero to 10 represents the 2.5-97.5th percentile. | General population reference range. Most adults without sleep disorders score in this band. |
| 11-12 | Mild Excessive Daytime Sleepiness (EDS) | Mild hypersomnolence; may be noticeable in high-somnificity situations (passive activities) | Mild OSA (AHI 5-15), early narcolepsy, sleep restriction (chronic insufficient sleep) |
| 13-15 | Moderate Excessive Daytime Sleepiness (EDS) | Clearly abnormal; dozing occurs even in moderately engaging activities (watching TV, reading) | Moderate-severe OSA (AHI 15-30), narcolepsy (some), idiopathic hypersomnia, severe sleep restriction |
| 16-24 | Severe Excessive Daytime Sleepiness (EDS) | Profound hypersomnolence; dozing during minimally somnificent activities (driving, talking, eating) | Severe OSA (AHI >30), narcolepsy (typical 16-24), severe idiopathic hypersomnia, Kleine-Levin syndrome (episodic) |
ESS vs Other Sleepiness/Fatigue Scales
| Scale | Construct Measured | Time Frame | Items (n) | Administration | Strengths | Limitations |
|---|---|---|---|---|---|---|
| Epworth Sleepiness Scale (ESS) | Average sleep propensity (dozing tendency) | "In recent times" (weeks to months) | 8 | 2-3 minutes self-report | Widely validated, MCID established (2-3 points), available in many languages, correlates with functional outcomes (driving, work performance) | Subjective, does NOT measure fatigue (only sleepiness), poor correlation with MSLT in some studies, requires literacy |
| Stanford Sleepiness Scale (SSS) | Current subjective drowsiness (momentary) | "Right now" (this minute) | 1 (7-point scale) | 10 seconds | Very quick, captures circadian variation, sensitive to sleep deprivation acutely | Does NOT measure trait sleepiness, fluctuates hour-to-hour, not stable for diagnosis |
| Karolinska Sleepiness Scale (KSS) | Current level of alertness (9-point) | "Right now" (this minute) | 1 (9-point scale) | 10 seconds | Validated for driving simulators, real-time monitoring, sensitive to sleep loss | Momentary only, requires real-time assessment (cannot recall historically) |
| Multiple Sleep Latency Test (MSLT) | Objective sleep propensity (physiologic) | Day of testing (4-5 nap opportunities) | N/A (polysomnography-based) | Full day in sleep lab | Objective (no reporting bias), gold standard for narcolepsy (SOREMPs), used for legal/disability | Expensive, time-consuming, poor correlation with subjective sleepiness in some populations, one-day snapshot |
| Maintenance of Wakefulness Test (MWT) | Ability to stay awake (objective) | Day of testing (4 trials) | N/A (polysomnography-based) | Full day in sleep lab | Objective, better for treatment response (CPAP, stimulants), used for driving/occupational assessment | Expensive, ceiling effects in normal individuals, not diagnostic for narcolepsy |
| Fatigue Severity Scale (FSS) | Fatigue (weariness, exhaustion) | "Past week" | 9 | 5-10 minutes | Standard for fatigue in MS, Parkinson's, post-viral syndromes | Confounded with depression, does NOT measure sleepiness (overlaps but distinct construct) |
| PROMIS Sleep Disturbance | Sleep quality and disturbances | "Past 7 days" | 8a short form (6-8 items) | 5 minutes | Computer adaptive testing available, NIH-funded, good for research | Less specific for sleepiness vs sleep quality |
Related Scores in Practice
In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the STOP-BANG (Sleep Apnea), Berlin Questionnaire, Pittsburgh Sleep Quality Index or the Mchat to formulate a comprehensive care plan.
Last Comprehensive Review: 2026